Corcept Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Corcept Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Corcept Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Corcept Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Corcept Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Corcept Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
James N. Wilson
Chairman Executive BoardMr James N. Wilson has been the Chairman of the company since 1999. Prior to this, he served as the Chairman of NuGEN Technologies, Inc. Previously, he served as the Director and Chairman at Amira Medical, Inc. Previously, he served as the Chief Operating Officer at Syntex Corporation from 1991 to 1994. He also served as the Chief Executive Officer of LifeScan, Inc. from 1982 to 1988.
Joseph K. Belanoff, M.D.
Chief Executive Officer; Director; President Executive BoardDr Joseph K. Belanoff has been the President, Chief Executive Officer and Director of the company since 2014. Prior to this, he served as the Director of Psychopharmacology at the outpatient division of the Palo Alto Veterans Affairs Hospital. Previously, he served as the Clinical Faculty Member and held various positions in the Department of Psychiatry and Behavioural Sciences at Stanford University.
Atabak Mokari
Chief Financial Officer; Treasurer Senior ManagementMr Atabak Mokari has been the Chief Financial Officer and Treasurer of the company since 2021. Prior to this, he was Chief Financial Officer and Vice President of Corporate Development at Bellicum Pharmaceuticals, Inc from 2018 to 2020. Previously, he served at the medical device manufacturer, IRIDEX, from 2016 to 2018. He also served as a director at Wells Fargo Securities LLC. Previously, Mr Mokari has 20 years of leadership experience in life sciences and healthcare finance.
Hazel Hunt Ph.D.
Chief Scientific Officer Senior ManagementDr Hazel Hunt has been the Chief Scientific Officer of the company since 2020. Prior to this, she served as the Senior Vice President, Research of the company. Previously, she served as the Director of Chemistry and Operations at Argenta from 2002 to 2011. She also served as a Research Fellow at The Centre for Drug Design and Development from 1992 to 1994.
Joseph D. Lyon
Chief Accounting and Technology Officer Senior ManagementMr Lyon has been the Chief Accounting and Technology Officer of the company since 2024. Prior to this, he served as the Vice President and Corporate Controller at the company. He has also served in various positions at the company since 2011. Previously, he also worked with Zinfi Technologies, Inc and Ernst & Young, Inc.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer